Caption Guidance, the company’s transformational ultrasound software, successfully meets primary endpoints in pivotal clinical study Food and Drug Administration (FDA) grants Breakthrough Device Designation to Caption Guidance SAN FRANCISCO, Oct. 1, 2019 /PRNewswire/ — Bay Labs, a growing medical technology company applying deep learning technology to emulate the expertise of highly-trained medical experts, […]
Financial
Sensydia Appoints Anthony Arnold as President and Chief Executive Officer
LOS ANGELES–(BUSINESS WIRE)–Sensydia Corporation, an innovator in rapid, non-invasive measurement of critical cardiac function, announced that industry leader Anthony Arnold has been appointed as chief executive officer and president and joins the Board of Directors. Arnold is a pioneer in bioelectronic medicine and surgical navigation and brings more than 20 years of […]
LUMEDX Announces Industry Partnership With MedAxiom
Leaders in business intelligence and the cardiovascular space use knowledge exchange and thought leadership in working towards better care and lower costs LUMEDX, a market leader in cardiovascular information systems (CVIS) and cutting-edge business intelligence solutions for more than 25 years, is excited to announce its industry partnership with MedAxiom, […]
Endonovo Therapeutics Appoints Dr. William Li as Strategic Advisor to the CEO
Los Angeles, CA, Sept. 30, 2019 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”) today announces it has appointed Dr. William Li as Strategic Advisor to the CEO. Dr. Li and Endonovo CEO Alan Collier will work collaboratively and strategically to explore growth strategies for Endonovo’s […]
Resverlogix Announces US$12 Million Debenture Financing and Full Repayment of Loan
CALGARY, Alberta, Sept. 27, 2019 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX: RVX) today announces that it has issued a 10% secured convertible debenture in the principal amount of US$12 million (the “Debenture”) to a wholly-owned subsidiary of ORI Star Fund LP (“ORI” or the “Fund”). The […]
Access Vascular Secures New Financing to Accelerate Commercialization
BEDFORD, Mass., Sept. 26, 2019 /PRNewswire/ — Access Vascular, a medical device company developing the next generation of intravenous devices from novel biomaterials designed to minimize the risk of bloodstream infection, catheter thrombosis, and vein trauma, announced $6M in new funding from new and existing investors. With this new round, Access Vascular is poised to […]
BD Announces Leadership Succession Plan
FRANKLIN LAKES, N.J., Sept. 26, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Vincent A. Forlenza, chairman and CEO, will retire as CEO on Jan. 28, 2020, following the company’s annual meeting of shareholders. Forlenza will continue on the BD board of directors, serving as […]
United Biologics, Inc. Appoints John Barnhill as Its President and General Manager
SANTA ANA, Calif.–(BUSINESS WIRE)–United Biologics, Inc., a global leader in silicone vasculature, today announced the appointment of John Barnhill as President and General Manager. As President and General Manager, Mr. Barnhill will guide the company’s commercial advancement and innovation strategies, as well as oversee all financial and operations infrastructure to […]
AI-Powered Digital Health Company Eko Closes $20 Million Series B to Continue the Fight Against Heart Disease
Led by ARTIS Ventures, Funding will Drive Further Research and Commercialization of Eko’s Machine Learning Platform San Francisco, CA, Sept. 25, 2019 (GLOBE NEWSWIRE) — Eko, a Silicon Valley-based digital health company building machine learning tools to fight heart disease, today announced it has secured $20 million in Series B funding. […]
Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased market expansion
Malmö, 25 September 2019 Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased market expansion The board of directors of Acarix AB (“Acarix” or the “Company”) has today, pursuant to the authorization granted by the extra general meeting on 16 August 2019, resolved to […]



